Farmmi is a Cayman Islands holding company that is unwinding its Chinese edible fungi trading business after a strategic decision to substantially reduce PRC operations, leaving a nascent U.S. warehouse and logistics franchise as the sole remaining operating engine.
The most consequential event of the past six months is the recognition of a massive net loss for the half year ended March 31, 2026. The loss was driven by a $29.1 million allowance for credit losses on supplier advances that management determined to be unrecoverable after the strategic pivot away from PRC purchasing. The mechanism is straightforward: the company had pre-paid a large balance to Chinese agricultural suppliers on the expectation of future mushroom and commodity purchases, but once management decided to exit those operations, the advances became stranded receivables rather than working capital.
The tension for shareholders is that the remaining business is small, unproven, and structurally dependent on a single contract. The logistics segment ran a gross loss in the first half of fiscal 2026 as the one-piece shipping service under the December 2024 distribution agreement remains in its gestation period. The company entered the period with $0.2 million in cash, and survival depends on continued equity dilution at sub-dollar prices.
The catalyst to watch is whether the U.S. warehouse network, now spanning three leased facilities in California and New Jersey, can attract a second logistics customer beyond the single unrelated third party that currently drives substantially all segment revenue.
Farmmi, Inc. is a Cayman Islands exempted company incorporated in July 2015, listed on the Nasdaq Capital Market under the ticker FAMI since its February 2018 initial public offering. The company conducts operations through wholly owned subsidiaries in the People's Republic of China and the United States, and files as a foreign private issuer under Form 20-F and Form 6-K. The dual-class share structure gives Class B shares fifty votes per share against one vote for each Class A share, and the Class B shares, held almost entirely by founders Yefang Zhang and Zhengyu Wang, retain effective control of the board despite holding a small economic stake.
The company's origins trace to the Lishui region of Zhejiang Province, a part of China historically recognized as a major production base for dried shiitake mushrooms and black ear fungus. Founders Zhang and Wang began trading dried edible fungi in 1994, and over two decades built a processing and distribution operation in the Lishui area with fewer than eighty factory workers. The core business model is commodity trading rather than cultivation: Farmmi purchases dried mushrooms and other agricultural products from regional family farms and trading companies, processes and packages them, and sells to a small number of wholesale customers, historically concentrated in a single buyer that accounted for 68 percent of fiscal 2025 revenue.
The strategic pivot away from PRC operations, finalized after the September 30, 2025 fiscal year end, represents a fundamental repositioning. The company is now effectively a U.S. logistics and warehousing business in early innings, with the Chinese trading operations in a wind-down phase. The December 2024 overseas warehouse distribution service agreement, which established the one-piece shipping service model, is the commercial foundation of the new direction, and the January 2026 FDA food facility registration for the U.S. subsidiary extends the addressable product range beyond mushrooms into broader food and agricultural commodities.
The competitive landscape in the Chinese dried-mushroom segment is fragmented, with low barriers to entry and established regional competitors such as Zhejiang Jingning Nature Food and Zhejiang Tianhe Food operating larger facilities in the same Lishui area. Farmmi's prior competitive positioning rested on quality differentiation, long-standing supplier relationships, and the geographic proximity of its factories to the Qingyuan and Longquan mushroom-growing towns. That positioning has now become largely irrelevant to the forward thesis, because the company is exiting the very segment where those advantages existed.
The product portfolio in wind-down mode covers dried shiitake mushrooms, dried black ear fungus, and a rotating set of agricultural commodities including tapioca, corn, cotton, and cornstarch. The revenue decline in fiscal 2025 was volume driven rather than price driven, with average unit selling prices essentially flat year over year. The sales volume contraction in shiitake and black ear fungus reflects reduced customer order flow in a maturing Chinese mushroom market that the company itself described as moving from rapid expansion to a more mature stage.
The U.S. warehouse and logistics segment operates three leased facilities in California and New Jersey, with the Chino, California location occupying the largest share of the footprint. The Chino facility provides dedicated railway lines for sea-rail cargo transport, and the two New Jersey locations, in Somerset and Robbinsville, extend the network to the East Coast. The U.S. subsidiary completed a Food and Drug Administration facility registration in January 2026, which broadens the range of food and agricultural commodities it can store and distribute.
The operational technology is a third-party developed Warehouse Management System that the company rents rather than owns. The WMS handles online order management, inventory tracking, intelligent stocking analysis, settlement reconciliation, and delivery lifecycle management. The company describes the one-piece shipping service as an end-to-end overseas warehousing and fulfillment arrangement in which Farmmi provides cargo transfers, bonded warehouse storage, in-warehouse operations, and final-mile delivery to a single unrelated third-party customer under a December 2024 distribution service agreement.
The moat question for the U.S. segment is whether the facility footprint, the FDA registration, and the railway access at Chino create switching costs or network effects that would deter a third-party logistics competitor from replicating the offering. At this stage, the answer is uncertain. The segment has one customer, no proprietary technology, and lease obligations rather than owned real estate. The right-of-use asset and the associated lease liabilities indicate that the capital commitment is contractual rather than owned, which limits the defensibility of the asset base.
Total revenue for the most recent full fiscal year fell 56 percent to $28.0 million. The logistics segment, which contributed a nominal amount in the prior year, grew to represent 26 percent of total revenue in fiscal 2025, marking the first year in which the U.S. operations represented a material share of the top line.
The first half of fiscal 2026 produced a net loss of $37.6 million, a dramatic widening from the prior year period. The dominant line item was the $29.1 million charge for credit losses on supplier advances. Management determined that a significant portion of the supplier prepayment balance was no longer recoverable following the strategic exit from PRC purchasing. A $7.0 million impairment on the long-term investment in the forestry acquisition that was terminated in September 2025 added a second non-cash charge to the period.
Revenues for the half year declined 60 percent to $6.4 million. The decline was broad based across all product lines. Shiitake revenue fell 72 percent and black ear fungus revenue fell 65 percent. Logistics services declined 21 percent to $2.7 million. The logistics segment ran a gross loss for the period, which management attributed to the gestation period of the one-piece shipping service that commenced in December 2024. Operating cash flow was negative $1.3 million, a sharp reversal from the positive cash flow in the comparable prior year period, which had been supported by the build-up of supplier advances and note receivables that are no longer recurring.
The balance sheet at the reporting date showed total assets of $114.9 million. The largest asset items were note receivables, supplier advances, and accounts receivable, all of which are dependent on collections and recoveries that remain uncertain. Cash stood at $0.2 million. Shareholders equity for Farmmi was $91.5 million, but this figure includes an $18.0 million subscription receivable that reduces net tangible equity and reflects equity issued in connection with the recent financing rounds where full cash consideration had not yet been received at the balance sheet date. The accumulated deficit widened over the six months, entirely driven by the non-cash impairment and credit loss charges.
The forward thesis rests on a single variable: whether the U.S. logistics segment can scale beyond its current single-customer revenue base. The one-piece shipping service agreement signed in December 2024 is the only contracted source of segment revenue, and the segment ran a gross loss in the most recent reporting period. Management has not disclosed a second customer, a pipeline of prospective customers, or a specific revenue target for the segment. The execution risk is therefore binary: either the Chino and New Jersey facilities attract additional food and agricultural shippers within the next several quarters, or the company is operating a fixed-cost lease portfolio with one customer and no path to breakeven.
The strategic decision to substantially reduce PRC operations, finalized after the fiscal 2025 year end, carries its own execution risk in the wind-down. The write-down in the first half of fiscal 2026 leaves a residual supplier advance balance still on the books, and the company also retains a substantial note receivable balance largely connected to the terminated Senbo Forestry transaction. The recoverability of both items is not assured, and any further write-down would directly reduce net equity. The company entered the period with a going concern qualification in the unaudited financial statements, and the equity financings raised after the reporting date may not be sufficient to remedy the condition.
The capital structure risk is the most immediate constraint. With minimal cash on hand at the reporting date, the company has raised a substantial amount in gross proceeds through equity financings in the period after the reporting date, including a registered direct offering at a sub-dollar price in June 2026. The June 2026 prospectus supplement offered millions of Class A shares and pre-funded warrants, a structure that represented a significant discount to the market closing price. The dilution implied by those offerings, combined with the warrant overhang, is substantial relative to the existing share count, and the company has explicitly stated that further dilution is likely to be required.
The FDA food facility registration completed in January 2026 is a genuine operational milestone for the U.S. segment, because it permits the storage and distribution of a broader range of food and agricultural commodities than the company could handle before. The registration is a prerequisite for many grocery and food-service customers that require FDA-registered storage facilities. The consequence for shareholders is that the segment now has a regulatory credential that lowers the barrier to adding new customers, but the credential alone does not generate demand. The timing question is whether the company can convert the regulatory qualification into contracted revenue before the cash runway exhausts the dilution capacity of the equity.
The customer concentration risk is the most acute operational vulnerability. In fiscal 2025, a single customer accounted for 68 percent of total revenue. The logistics segment revenue is substantially all generated by one unrelated third party under the December 2024 distribution agreement. The loss of either customer would remove the majority of remaining revenue. The Yunmihui relationship was in the PRC trading business that is now in wind-down, so the relevant concentration risk has shifted to the single logistics customer, whose contract terms, renewal schedule, and volume trajectory are not disclosed in detail.
The supplier recovery risk is the largest balance sheet overhang. The residual supplier advances and the note receivables together represent a substantial portion of total assets whose value is dependent on collections from PRC counterparties and from the terminated forestry transaction. A further impairment of even half of that amount would reduce shareholders equity by a wide margin, which at the current share count would imply a book value per share in the low single digits. The going concern qualification in the March 31, 2026 financial statements formalizes the liquidity risk, and the company has stated that the equity financings raised after the reporting date may not be sufficient to remedy the condition.
The dilution risk operates on a continuous cycle. The company has issued equity at progressively lower prices throughout fiscal 2026, from the sub-dollar June 2026 offering to the sub-dollar warrant exercises that contributed a meaningful amount of financing cash flow in the first half. The 4.5 billion authorized Class A shares provide substantial headroom for further issuance, and the Class B control structure means the founders can retain voting control even as their economic stake is diluted. The consequence for new shareholders is that the per-share claim on the U.S. logistics asset base is being continuously reduced by the financing cadence required to fund operations.
The regulatory and structural risk of the Cayman holding company structure with PRC operating subsidiaries persists even as the PRC operations shrink. The company has disclosed that PRC regulations could disallow the holding company structure, and the divestiture of Farmmi Food and Farmmi Supply Chain to a third party for a nominal cash consideration in March 2025 illustrates the difficulty of extracting value from the Chinese entities. The counterargument to the bear case is that the company is not in immediate operational distress for the U.S. segment. The three warehouse facilities are leased with multi-year obligations that run beyond 2026, the FDA registration is in place, and the one-piece shipping service has a contracted customer with a demonstrated revenue track record in fiscal 2025. The non-cash charges that drove the net loss do not consume cash, and the operating cash burn in the first half of fiscal 2026 was limited relative to the asset base. A company with a sub-$2 million quarterly cash burn and a multi-warehouse footprint is not in immediate distress, provided the equity market continues to provide access to capital at prices that do not destroy the remaining per-share value.
Valuing Farmmi on a conventional earnings multiple is not possible, because the company is loss-making and the earnings base is dominated by non-cash charges that do not recur. The appropriate framework is a sum-of-the-parts analysis that values the U.S. logistics asset base, the PRC residual receivables, and the net cash position separately, then applies a discount for dilution risk, customer concentration, and the going concern qualification. The U.S. logistics segment is the only operating business with a forward revenue trajectory, and a reasonable valuation of the segment, assuming it reaches positive gross margin within twelve to eighteen months and attracts at least one additional customer, is in the range of $15 million to $30 million in enterprise value.
The PRC residual receivables, comprising supplier advances and note receivables, are best valued at a significant discount to book. The $31.7 million write-down in the first half of fiscal 2026 demonstrates that management itself has already determined that a large portion of the original supplier advance balance was unrecoverable. The residual supplier advances should be valued at a low range, and the note receivables, largely connected to the terminated Senbo Forestry transaction, should be valued at a low range as well. A midpoint estimate for the combined residual receivables is optimistic and should be treated as a bear-to-base range.
The base case enterprise value combines the U.S. segment at a mid-point value and the residual receivables at a mid-point value, giving a gross asset value of roughly $30 million. Subtracting the total liabilities as of the reporting date and adding the minimal cash balance, the net equity value is approximately $6 million. The bear case, which values the residual receivables at zero and the U.S. segment at a low value, implies a net equity value of approximately $2 million. The bull case, which values the U.S. segment at a high value on the assumption of successful multi-customer scaling and positive gross margin, implies a net equity value of approximately $21 million, before further dilution.
The June 2026 offering at a sub-dollar price, which raised gross proceeds from the sale of millions of units, implies a post-offering share count of approximately 42 million Class A shares. At that share count, the base case per-share value falls below the offering price, the bear case falls below the 52-week low, and the bull case remains well above the current trading price. The 52-week trading range brackets all three scenarios, with the current price sitting near the bear case level. The valuation is therefore a function of dilution as much as operations, and the per-share value is structurally capped by the pace of equity issuance required to fund the cash burn.
The investment case for Farmmi is a bet on the U.S. logistics segment's ability to scale from a single-customer, gross-loss-making operation into a multi-customer, positive-margin warehousing business before the dilution cycle erodes the per-share claim on the asset base to the point of irrelevance. The company has genuine operational assets in the form of three FDA-registered warehouse facilities in California and New Jersey, a contracted logistics customer, and a FDA registration that broadens the addressable product range. Those assets are real, and the fiscal 2025 logistics revenue is a legitimate proof of concept that the one-piece shipping service model can generate meaningful top line.
The fundamental problem is that the assets are small relative to the capital requirements. The minimal cash balance at the reporting date, the going concern qualification, and the $1.3 million operating cash burn in a half year mean that the company is structurally dependent on equity markets for survival. The $8.8 million raised after the reporting date extends the runway by approximately eight to twelve months at the current burn rate, which is a meaningful extension but not a solution. The per-share value in the base case is a range of a few cents to twenty cents on a post-dilution share count, which is below the price at which the most recent equity was issued, creating a situation in which new investors are buying at a premium to the base case fundamental value.
The bear case, which values the PRC residual receivables at zero and the U.S. segment at a low value, implies a per-share value of a few cents on a post-dilution basis, which is below the 52-week low. The bull case, which requires successful multi-customer scaling and positive gross margin within the next twelve to eighteen months, implies a per-share value of around fifty cents, which is below the 52-week high and well above the current trading price. The asymmetry between the bear and bull cases is large, but the probability weighting favors the bear case because the single-customer concentration, the gross loss trajectory, and the dilution cycle are all operating against the equity at the same time.
The judgment is that Farmmi is a speculative micro-cap with a real but small operating asset, a large balance sheet overhang from PRC residual receivables, and a financing structure that continuously dilutes the per-share value. The U.S. logistics segment is the only component of the business that has a defensible forward narrative, and the FDA registration is a genuine operational milestone. The company is not in immediate default, and the non-cash charges that drove the net loss do not consume cash. But the probability of a meaningful per-share recovery depends on the logistics segment attracting additional customers and reaching positive gross margin before the next financing round resets the share count at a lower price. The stock is a binary event-driven vehicle, not a value investment, and the risk-reward profile is only favorable for investors who can accept the possibility of a total loss of capital in exchange for the asymmetric upside of a successful logistics scaling outcome.